Discovery and Validation of Genetic Variants Affecting Microglial Activation in Alzheimer's Disease (AD) with 11C-ER176
Sponsor: |
NIH |
Enrolling: |
Male and Female Patients |
Clinic Visits: |
3 |
IRB Number: |
AAAT2774 |
U.S. Govt. ID: |
NCT04840979 |
Contact: |
Catriona Calvo-Studdy: 212-305-1625 / cc5280@cumc.columbia.edu |
The purpose of this study is to determine whether different genes are related to the amount of immune cell activity that occurs in the brain in patients with Alzheimer's disease. Participation in this study involves memory testing, a blood draw, MRI, and three PET scans. The second PET scan will involve putting a catheter in your wrist to draw blood during the scan. You will be compensated $700. After one year or so, we will invite you back to repeat some tests.
Investigator
Philip De Jager, PhD
Do you have either amnestic mild cognitive impairment or Alzheimer's disease? |
Yes |
No |
Are you able to get a MRI or PET scanners? |
Yes |
No |
Do you have written and oral fluency in English? |
Yes |
No |
Are you 50 years of age or older? |
Yes |
No |